In April this year, members were informed of the TGA listing compliance review outcomes for medicines containing the ingredient  Euphausia superba (Krill) Oil. At the time CMA provided information to assist sponsors to conduct a review of indication(s) for Krill oil and to voluntarily make any necessary amendments.

Having provided sponsors with the opportunity to make  amendments, the TGA will now follow up directly with sponsors of affected medicines.

Click here to read the Alert